Jason Miller is an Ophthalmology physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 Wall St
Ann Arbor, MI 481051912
Telephone
734-764-4190Provider last certified this registry record 8 Apr 2024.
Clinical trials
- Apioc Toric/Spherical Single Vision Contact Lens
Sponsor: Lentechs, LLC
- CSD170201: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products
Sponsor: RAI Services Company
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Research LLCProgram year20251 payment$90,000openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202512 payments$13,575openpaymentsdata.cms.gov ↗
- Cardinal Health 110 LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
68.3%Carbonic Anhydrase Inhibitor31.7%Dorzolamide-Timolol100%Part D≥14 patientsCorticosteroid24.8%Prednisolone Acetate100%Part D≥15 patients+ 1 more class in this area
Musculoskeletal
20.8%Cyclooxygenase Inhibitor20.8%Ketorolac Tromethamine100%Part D<11 patientsAnti-infectives
10.9%Macrolide10.9%Erythromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- Lipid Trafficking and Metabolism in the Retinal Pigment Epithelium
University of Michigan at Ann Arbor
FY2026$240,092K08EY033420 - Lipid Trafficking and Metabolism in the Retinal Pigment Epithelium
University of Michigan at Ann Arbor
FY2025$240,092K08EY033420 - Lipid Trafficking and Metabolism in the Retinal Pigment Epithelium
University of Michigan at Ann Arbor
FY2024$240,092K08EY033420
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”